BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25248898)

  • 1. [Metastatic breast cancer with microangiopathic hemolytic anemia successfully treated by using eribulin].
    Morita M; Fukuda K; Konishi T; Kiuchi J; Umehara S; Nakashima S; Fujiyama J; Masuyama M
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1139-41. PubMed ID: 25248898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Maintenance of Long-Term Stable Disease(SD)in Metastatic Breast Cancer with Eribulin - A Case Report of Long-Term SD in Japan].
    Nitta T; Kimura K; Tominaga T; Fujii K; Sato N; Ikari A; Miyoshi K; Tanaka S; Ishibashi T; Iwamoto M
    Gan To Kagaku Ryoho; 2016 Dec; 43(13):2543-2546. PubMed ID: 28028262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France.
    Hurtaud A; Donnadieu A; Escalup L; Cottu PH; Baffert S
    Breast; 2016 Dec; 30():73-79. PubMed ID: 27639032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Microangiopathic Hemolytic Anemia with Bone Marrow Carcinomatosis from Breast Cancer].
    Murakami A; Kamei Y; Kusakabe E; Yamasawa H; Aoki R; Komatsu S; Taguchi K; Nishiyama K; Yamashita M; Sugimori W; Asai H; Mizuno Y; Takada Y
    Gan To Kagaku Ryoho; 2018 Jul; 45(7):1105-1107. PubMed ID: 30042282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
    Catania G; Malaguti P; Gasparro S; Cognetti F; Vidiri A; Fabi A
    Oncology; 2018; 94 Suppl 1(Suppl 1):29-33. PubMed ID: 30041177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of stage IV breast cancer successfully treated over 1 year with eribulin as fourth-line systemic chemotherapy].
    Ishiyama T; Jinguu A; Matsumoto H; Kikuchi J; Suzuki T
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1433-5. PubMed ID: 25434450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of skeletal and bone marrow metastases from breast cancer treated with eribulin mesylate.
    Pashaj E; Cortesi L; Proietto M; Bonacorsi G; Liardo E; Federico M
    Future Oncol; 2013 Oct; 9(10):1437-42. PubMed ID: 24106895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal metastasis regression with eribulin in a heavily pretreated breast cancer patient.
    Gubbiotti M; Pistilli B; Tudini M; Benedetti G; Galizia E; Rusiello M; Latini L
    Future Oncol; 2015; 11(15 Suppl):17-22. PubMed ID: 26235260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of brain metastases from breast cancer with eribulin: a case report.
    Matsuoka H; Tsurutani J; Tanizaki J; Iwasa T; Komoike Y; Koyama A; Nakagawa K
    BMC Res Notes; 2013 Dec; 6():541. PubMed ID: 24350786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer.
    Rasmussen ML; Liposits G; Yogendram S; Jensen AB; Linnet S; Langkjer ST
    Acta Oncol; 2014 Sep; 53(9):1275-7. PubMed ID: 24844919
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with eribulin in patients with metastatic breast cancer and associated hepatic impairment: case studies.
    Acosta-Eyzaguirre D; Calvo Plaza I; Perelló Martorell A; Hernández Agudo E; García-Estévez L
    Future Oncol; 2018 Mar; 14(7s):29-36. PubMed ID: 29611757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term response to eribulin in patients with metastatic breast cancer-report of 2 cases].
    Hara Y; Sakurai K; Nagashima S; Suzuki S; Waga E; Matsumoto K; Hagiwara M; Maeda T; Hirano T; Enomoto K; Tani M; Amano S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2372-4. PubMed ID: 24394116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trial.
    Fabi A; Terrenato I; Vidiri A; Villani V; Tanzilli A; Airoldi M; Pedani F; Magri V; Palleschi M; Donadio M; Catania G; Nisticò C; Carapella C; Rudà R; Pace A; Maschio M; Telera S; Cognetti F;
    Future Oncol; 2021 Sep; 17(26):3445-3456. PubMed ID: 34044585
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathological Complete Response Obtained by Eribulin Chemotherapy in a Case of Advanced Breast Cancer].
    Asano Y; Kashiwagi S; Goto W; Takada K; Morisaki T; Takashima T; Noda S; Onoda N; Ohsawa M; Hirakawa K; Ohira M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2240-2242. PubMed ID: 28133282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eribulin efficacy based on type of metastatic site: a real-life study in heavily pretreated metastatic breast cancer.
    Prestifilippo A; Grippaldi D; Blanco G; Memeo L; Puliafito I; Giuffrida D
    Future Oncol; 2017 Apr; 13(11s):5-10. PubMed ID: 28481186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice.
    Fabi A; Moscetti L; Ciccarese M; Caramanti M; Salesi N; La Verde N; Russillo M; Generali D; Scandurra G; Vari S; Pacetti U; Cognetti F; Giannarelli D
    Future Oncol; 2015; 11(3):431-8. PubMed ID: 25675124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of eribulin for metastatic breast cancer patients].
    Okishiro M; Egawa C; Kusama H; Matsushita K; Hashimoto N; Kawashima H; Mukai Y; Hamanaka M; Takeno A; Sakisaka H; Nakahira S; Taniguchi H; Suzuki R; Takeda Y; Kato T; Tamura S; Takatsuka Y
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):215-9. PubMed ID: 24743200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two Cases in Which Eribulin Mesylate Was Effective for Taxane-Resistant Advanced Breast Cancer].
    Adachi K; Suzuki S; Kubota H; Hara Y; Fujiwara A; Waga E; Hirano T; Enomoto K; Sakurai K; Makishima M; Koshinaga T
    Gan To Kagaku Ryoho; 2017 Oct; 44(10):938-940. PubMed ID: 29066702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival with eribulin monotherapy after whole brain radiation therapy in a patient with brain metastasis from breast cancer.
    Jung SU; Jeon CW; Choi JH
    Asian J Surg; 2020 Oct; 43(10):1008-1009. PubMed ID: 32631621
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with eribulin in patients with breast cancer and cutaneous metastases: case studies.
    Espinosa Aunión R; Ramírez Ruda CA; Rodríguez López C; Curiel García T; García Saénz JÁ; López López R
    Future Oncol; 2018 Mar; 14(7s):37-44. PubMed ID: 29611759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.